Institution: Eidogen-Sertanty

steve muskal

Cutting the Cord: How ChemAxon Technology Inspired and Enabled our Liberation into the Cloud

Sep 24, 2013 - Presentation
Cloud computing offers the promise of lower cost, scalable, ‘utility’ computing. While many of us have had growing use and in some cases a dependence on cloud-based compute po…
kinome

The Mobile Kinome 

May 20, 2010 - Presentation
Kinases are now one of the most intensely pursued classes of drug targets with approximately 30 distinct kinase targets and over 200 kinase inhibitors in clinical development. Keeping up …

Novel Kinase Inhibitors by Reshuffling Ligand Functionalities Across the Human Kinome

Nov 5, 2012 - Publication
Protein kinases remain among the most versatile and prospective therapeutic drug targets with currently 15 distinct compounds approved for use in humans and numerous clinical development …